Pharmaceutical care on a lung adenocarcinoma patient with pulmonary embolism and pulmonary infection
HOU Ji-qiu
WANG Dong-xue
ZHU Man
SUN Jing
Abstract：One 44-year-old female patient was admitted to the hospital due to hemoptysis. The diagnosis was lung adenocarcinoma and pulmonary embolism. The pulmonary embolism was treated with low molecular weight heparin and warfarin. On the 12th day after admission, the patient developed pulmonary infection. Moxilfoxacin was given to the patient and transferred to vancomycin 3 days later. After 3 days, imipenem/cilastatin was added. The patient improved a week later. Simultaneous chemotherapy with pemetrexed disodium and carboplatin was given to the patient on the 18th day after admission. Anticoagulant therapy and hemoptysis as well as chemotherapy and infection were contradictory during the treatment. Pharmacists assisted physicians in determining the main therapeutic contradiction, adjusting anti-infective drugs, assessing chemotherapy schedule and so on. The patient underwent the ifrst cycle of chemotherapy successfully and was discharged with the improved condition.
Keywords：Pharmaceutical careClinical pharmacistLung adenocarcinomaPulmonary embolismPulmonary infection
Publication Date：2015-01-01
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：3( 275-277 )